Taysha Gene Therapies News

Buy Rating Affirmed: Taysha Gene Therapies Poised for Breakthrough on Pediatric Data and FDA Support

TipRanksMay 16 04:17 ET

Analysts Offer Insights on Healthcare Companies: Sutro Biopharma (STRO), Athira Pharma (ATHA) and Taysha Gene Therapies (TSHA)

TipRanksMay 16 00:30 ET

Analysts Are Bullish on These Healthcare Stocks: Taysha Gene Therapies (TSHA), Biogen (BIIB)

TipRanksMay 15 08:21 ET

Truist Financial Reaffirms Their Buy Rating on Taysha Gene Therapies (TSHA)

TipRanksMay 15 07:27 ET

Taysha Gene Therapies (TSHA) Gets a Buy From Cantor Fitzgerald

TipRanksMay 15 07:16 ET

Earnings Call Summary | Taysha Gene Therapies(TSHA.US) Q1 2024 Earnings Conference

The following is a summary of the Taysha Gene Therapies, Inc. (TSHA) Q1 2024 Earnings Call Transcript:Financial Performance:Taysha Gene Therapies reported Q1 2024 research and development expenses of

moomoo AIMay 15 06:36 ET · Conference Call

Express News | Needham Reiterates Buy on Taysha Gene Therapies, Maintains $7 Price Target

BenzingaMay 15 06:04 ET

Analysts Offer Insights on Healthcare Companies: Chemed (CHE), Acadia Healthcare (ACHC) and Taysha Gene Therapies (TSHA)

TipRanksMay 15 06:02 ET

Taysha Gene Therapies Inc (TSHA) Q1 2024 Earnings Call Transcript Highlights: Navigating ...

Yahoo FinanceMay 15 03:11 ET

Taysha Gene Therapies Q1 Net Loss Narrows, Revenue Declines -- Shares Down After Hours

Taysha Gene Therapies (TSHA) reported Q1 net loss Tuesday of $0.10 per diluted share, narrower from a loss of $0.28 a year earlier. Analysts polled by Capital IQ expected a loss of $0.11 per share. Re

MT NewswiresMay 14 17:03 ET

Taysha Gene Therapies | 10-Q: Quarterly report

SEC announcementMay 14 16:24 ET · Announcements

Express News | Taysha Gene Therapies Inc: Continues to Expect Its Current Cash Resources Will Support Planned Operating Expenses & Capital Requirements Into 2026

ReutersMay 14 16:03 ET

Earnings Flash (TSHA) TAYSHA GENE THERAPIES Reports Q1 Revenue $3.4M, Vs. Street Est of $2.6M

04:02 PM EDT, 05/14/2024 (MT Newswires) -- Earnings Flash (TSHA) TAYSHA GENE THERAPIES Reports Q1 Revenue $3.4M, vs. Street Est of $2.6M

MT NewswiresMay 14 16:02 ET

Express News | Taysha Gene Therapies Q1 EPS USD -0.1 Vs. Ibes Estimate USD -0.11

ReutersMay 14 16:01 ET

Express News | Taysha Gene Therapies Q1 Operating Expenses USD 27.741 Million

ReutersMay 14 16:01 ET

Express News | Taysha Gene Therapies Q1 Net Income USD -24.061 Million Vs. Ibes Estimate USD -19.3 Million

ReutersMay 14 16:01 ET

Express News | Taysha Gene Therapies Q1 Basic EPS USD -0.1

ReutersMay 14 16:01 ET

Taysha Gene Therapies 1Q Loss/Shr 10c >TSHA

Taysha Gene Therapies 1Q Loss/Shr 10c >TSHA

Dow JonesMay 14 16:01 ET

Taysha Gene Therapies Upgraded at Jefferies on Rett Syndrome Asset

Seeking AlphaMay 14 12:45 ET

Taysha Gene Therapies Coverage Assumed by Jefferies at Buy Vs Previous Rating of Hold

Taysha Gene Therapies Coverage Assumed by Jefferies at Buy Vs Previous Rating of Hold

Dow JonesMay 14 08:30 ET